/C O R R E C T I O N — Public Interest Registry/
Public Interest Registry Announces 2025 .ORG Impact Awards Finalists, Artist & Actor…
Humbirdy Launches AI Bird Feeder 4K Ultra: Turning Backyards into Personal Nature Documentaries
New York, NY, Sept. 01, 2025 (GLOBE NEWSWIRE) -- For most people,…
Best Ally in the fight against corruption
HONG KONG, Aug. 28, 2025 /PRNewswire/ -- "Hong Kong, our advantage is…
Novo Nordisks Wegovy cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular diseas
Compared with tirzepatide, Wegovy® (semaglutide 2.4 mg) showed a significant 57% greater…
Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment
Abbott's denosumab biosimilar is the first approved in Thailand, making advanced therapy for…
Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline
BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ:…
First Phase of IIPD Kasaragod, a Model Project to Empower Individuals with Disabilities, to be Completed in 2026, Fully Operational by 2029
THIRUVANANTHAPURAM, India, Aug. 18, 2025 /PRNewswire/ -- The first phase of the…
AI adoption is strong among entry-level workers across sectors and economies – and it’s making work life easier and more enjoyable, reports Generation
Analysis finds that 65% of entry-level employees are using AI, and most…
Novo Nordisk A/S: Wegovy approved in the US for the treatment of MASH
Bagsværd, Denmark, 15 August 2025 – Novo Nordisk today announced that the US…
Appeal launched to support people impacted by Newfoundland fires
OTTAWA, Ontario, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The Canadian Red Cross…